永安藥業(002365.SZ):與浙江雙子簽訂設備製造及系統集成框架協議
格隆匯12月2日丨永安藥業(002365.SZ)公佈,公司於2021年12月2日召開第六屆董事會第四次會議審議通過《關於與浙江雙子智能裝備有限公司簽訂<設備製造及系統集成框架協議>暨關聯交易的議案》,同意公司及其子公司與浙江雙子智能裝備有限公司(“浙江雙子”或“乙方”)簽署《設備製造及系統集成框架協議》,合同有效期限為一年,交易總金額不超過人民幣1000萬元。
根據公司經營發展的需要,鑑於交易雙方在以往協議期間均能較好的履行協議規定的義務,公司擬與浙江雙子繼續合作,委託浙江雙子為公司及其子公司提供符合要求的設備及設備安裝、配套的信息系統搭建、調試應用等服務,有助於加快項目進度,保證公司生產經營計劃順利進行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.